Part D premiums likely to increase slightly in 2021: CMS

A document that reads 'Medicare Part D'
The Centers for Medicare & Medicaid Services released a look at Part D premiums for 2021 late Wednesday. (Getty/designer491)

Average Part D premiums are set to take a slight uptick in 2021, according to the Trump administration.

The Centers for Medicare & Medicaid Services (CMS) estimates the average basic premium in Part D will be $30.50 next year, a slight increase from $30 in 2020 but still the second-lowest premium rate ever.

Part D premiums have been on a steady decline over the past several years, decreasing by 12% since 2017, which represents close to $1.9 billion in premium savings for beneficiaries.

Featured Webinar

Reducing barriers to patient care: A cross-industry collaboration

Optum will bring together cross-industry experts to share a case study detailing how an employer, provider, payer and pharmaceutical company worked together to address migraines, a hard-to-diagnose condition. Learn how this team started with a model to risk stratify, predict undiagnosed, misdiagnosed and mismanaged members and how those analytics were used to enrich engagement for treatment and diagnosis optimization.

“At every turn, the Trump Administration has prioritized policies that introduce choice and competition in Part D,” CMS Administrator Seema Verma said in a statement. "Part D premiums continue to stay at their lowest levels in years even as beneficiaries enjoy a more robust set of options from which to choose a plan that meets their needs.”

RELATED: Medicare Advantage, Part D plans face uncertain healthcare world under COVID-19 as they develop bids

Part D enrollment has increased alongside declining premiums, CMS said, with enrollment increasing by 16.7% since 2017.

CMS also touted Trump administration efforts to curb costs for Part D beneficiaries, such as launching the Part D Senior Savings Model earlier this year, in which participating Part D plans will offer insulin with a cap at $35 for a monthly supply.

CMS also eliminated the so-called pharmacy "gag clause," which prevented pharmacists from providing beneficiaries with information on alternative, less expensive ways to purchase drugs than through their Part D plan.

President Donald Trump also signed four executive orders targeting drug pricing late last week, including one that aims to revive the scuttled rule that would nix anti-kickback safe harbors for drug rebates in Part D.

Suggested Articles

A New Jersey medical office has filed suit against Cigna, alleging that the insurer failed to pay for diagnostic testing and treatment for COVID-19.

CMS issued new guidance Friday to help states implement the new interoperability policies in Medicaid and CHIP programs.

GoodRx has released its latest list of the most expensive drugs in America, with orphan drugs and therapies for rare conditions topping the ranking.